Carregant...
Why continuing uncertainties are no reason to postpone challenge trials for coronavirus vaccines
To counter the pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), some have proposed accelerating SARS-CoV-2 vaccine development through controlled human infection (or ‘challenge’) trials. These trials would involve the deliberate exposure of relatively few young, healt...
Guardat en:
| Publicat a: | J Med Ethics |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7371490/ https://ncbi.nlm.nih.gov/pubmed/32661074 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/medethics-2020-106501 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|